🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this trial is to investigate the effects of a new class...
Status
Completed
Location
Northwestern University
Start Date
2016-11-01
Trial ID
NCT02794883
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of olaparib wh...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-06-29
Trial ID
NCT02953457
Treatments Being Tested
This is a randomized, open, comparative, multi-centre study which will recr...
Status
Completed
Location
Institut Ste Catherine
Start Date
2017-10-18
Trial ID
NCT03249142
The goal of this Phase 1b clinical trial is to evaluate the safety and effi...
Status
Active Not Recruiting
Location
University of California, San Diego
Start Date
2025-01-03
Trial ID
NCT06710223
Treatments Being Tested
A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability...
Status
Completed
Location
Research Site
Start Date
2014-05-22
Trial ID
NCT02141347
Treatments Being Tested
Combined-modality treatment of localized muscle invasive bladder cancer inc...
Status
Completed
Location
Instituto Catalán de Oncología Badalona
Start Date
2018-11-19
Trial ID
NCT03702179
Treatments Being Tested
This study is a pilot study of biomarker-driven targeted therapy in patient...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2018-11-26
Trial ID
NCT03699449
The purpose of this study is to determine the efficacy and safety of invest...
Status
Completed
Location
Research Site
Start Date
2015-04-15
Trial ID
NCT02319044
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Status
Recruiting
Location
City of Hope /ID# 261468
Start Date
2024-01-11
Trial ID
NCT06109272
Treatments Being Tested
Tremelimumab plus durvalumab (STRIDE regimen) is an approved first-line the...
Status
Recruiting
Location
Chang Gung Memorial Hospital at Linkou
Start Date
2025-05-22
Trial ID
NCT06999694
Treatments Being Tested